Braskem Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Braskem wird ein jährliches Gewinn- und Umsatzwachstum von 126.9% bzw. 5.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 118.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 80.5% betragen.

Wichtige Informationen

126.9%

Wachstumsrate der Gewinne

118.1%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	47.4%
Wachstumsrate der Einnahmen	5.1%
Zukünftige Eigenkapitalrendite	80.5%
Analystenabdeckung	Good
Zuletzt aktualisiert	18 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Gewinn- und Umsatzwachstumsprognosen

BOVESPA:BRKM5 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	84,281	3,186	N/A	7,563	7
12/31/2025	84,171	177	892	5,178	11
12/31/2024	79,452	-4,973	5,169	3,736	10
9/30/2024	74,950	-7,248	-1,329	2,632	N/A
6/30/2024	70,362	-9,073	-3,388	958	N/A
3/31/2024	69,043	-6,108	-2,741	1,495	N/A
12/31/2023	70,569	-4,579	-6,802	-2,272	N/A
9/30/2023	72,867	-4,715	-5,803	-975	N/A
6/30/2023	81,578	-3,400	-689	4,425	N/A
3/31/2023	89,234	-4,036	-874	4,440	N/A
12/31/2022	96,519	-336	4,103	8,951	N/A
9/30/2022	105,742	1,905	6,179	10,874	N/A
6/30/2022	108,654	6,545	9,671	13,676	N/A
3/31/2022	109,664	15,375	10,562	14,192	N/A
12/31/2021	105,625	13,985	11,365	14,786	N/A
9/30/2021	96,151	14,301	11,521	14,393	N/A
6/30/2021	83,844	9,351	7,118	9,627	N/A
3/31/2021	68,611	-548	4,111	6,455	N/A
12/31/2020	58,543	-6,692	3,533	6,293	N/A
9/30/2020	52,445	-10,460	547	3,371	N/A
6/30/2020	49,821	-9,935	204	3,201	N/A
3/31/2020	51,970	-7,375	231	3,362	N/A
12/31/2019	52,324	-2,798	-417	2,265	N/A
9/30/2019	54,520	46	-335	2,356	N/A
6/30/2019	57,500	2,278	947	3,669	N/A
3/31/2019	57,949	2,741	5,736	8,494	N/A
12/31/2018	58,000	2,867	6,544	9,250	N/A
9/30/2018	55,792	3,114	7,009	9,572	N/A
6/30/2018	51,605	2,569	N/A	8,930	N/A
3/31/2018	49,690	3,329	N/A	3,694	N/A
12/31/2017	49,261	3,857	N/A	2,462	N/A
9/30/2017	48,678	1,153	N/A	2,403	N/A
6/30/2017	48,498	1,238	N/A	3,293	N/A
3/31/2017	48,349	548	N/A	4,778	N/A
12/31/2016	47,664	-438	N/A	4,458	N/A
9/30/2016	47,547	2,188	N/A	5,284	N/A
6/30/2016	48,729	2,870	N/A	5,946	N/A
3/31/2016	48,599	3,556	N/A	5,890	N/A
12/31/2015	46,880	2,995	N/A	7,092	N/A
9/30/2015	46,562	2,965	N/A	7,700	N/A
6/30/2015	45,123	1,667	N/A	5,721	N/A
3/31/2015	44,384	710	N/A	5,822	N/A
12/31/2014	46,031	864	N/A	3,792	N/A
9/30/2014	45,203	812	N/A	2,857	N/A
6/30/2014	44,417	942	N/A	1,491	N/A
3/31/2014	43,311	699	N/A	2,703	N/A
12/31/2013	40,969	510	N/A	2,458	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: BRKM5 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (10.4%).

Ertrag vs. Markt: BRKM5 wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: BRKM5 wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: BRKM5Die Einnahmen des Unternehmens (5.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt BR (7.5% pro Jahr).

Hohe Wachstumseinnahmen: BRKM5Die Einnahmen des Unternehmens (5.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: BRKM5Die Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (80.5%).

Braskem Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Consensus EPS estimates fall by 38%

Consensus EPS estimates fall by 11%

Consensus EPS estimates fall by 22%

Consensus EPS estimates fall by 57%

Consensus estimates of losses per share improve by 33%

Consensus EPS estimates upgraded to R$0.96 loss

Recent updates

Consensus EPS estimates fall by 38%

Third quarter 2024 earnings: Revenues in line with analyst expectations

Second quarter 2024 earnings: EPS misses analyst expectations

Consensus EPS estimates fall by 11%

High number of new directors

Braskem S.A. Announces Executive Changes

Braskem S.A. Announces Change in the Composition of the Statutory Compliance and Audit Committee

First quarter 2024 earnings released

Consensus EPS estimates fall by 22%

Consensus EPS estimates fall by 57%

Consensus estimates of losses per share improve by 33%

Consensus EPS estimates upgraded to R$0.96 loss

Now 23% undervalued

Consensus estimates of losses per share improve by 58%

Full year 2023 earnings: EPS misses analyst expectations

Braskem S.A. to Report Fiscal Year 2023 Results on Mar 18, 2024

Now 32% overvalued

Braskem S.A. to Report Q3, 2024 Results on Nov 06, 2024

Consensus EPS estimates fall by 80%

Consensus EPS estimates fall by 61%

ADNOC Makes Fresh Bid to Buy Stake in Brazil's Braskem

New minor risk - Share price stability

Consensus EPS estimates upgraded to R$1.92 loss

Consensus EPS estimates fall by 10%

Consensus estimates of losses per share improve by 24%

Price target decreased by 13% to R$32.60

Consensus EPS estimates fall by 20%

Consensus EPS estimates fall from profit to R$1.89 loss, revenue upgraded

New major risk - Financial position

Second quarter 2023 earnings released

Petrobras Says Made No Decision on Acquiring Control of Braskem

First quarter 2023 earnings: Revenues in line with analyst expectations

Abu Dhabi National, Apollo Reportedly Offer $7.6 Billion for Braskem

Consensus EPS estimates increase by 209%

Consensus EPS estimates fall by 29%

Full year 2022 earnings: Revenues miss analyst expectations

Price target decreased by 7.1% to R$45.88

Consensus EPS estimates fall by 20%

Braskem S.A. to Report Q1, 2023 Results on May 04, 2023

Price target decreased by 11% to R$49.38

Consensus forecasts updated

Braskem S.A. Provides Update on Proposed Settlement

Consensus forecasts updated

Braskem S.A., Annual General Meeting, Apr 12, 2023

Braskem S.A. Announces Executive Changes

Consensus forecasts updated

Less than half of directors are independent

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Braskem Announces New Renewable Innovation Center in Lexington, Massachusetts

Consensus forecasts updated

Investor sentiment improved over the past week

Now 21% undervalued after recent price drop

Consensus forecasts updated

Consensus EPS estimates fall by 21%

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Braskem S.A. (BOVESPA:BRKM5) agreed to acquire Wise Plasticos S.A.

Now 20% undervalued after recent price drop

Consensus EPS estimates fall by 27%

Consensus forecasts updated

Braskem Releases First Ever Lineup of Sustainable 3D Printing Filaments for Additive Manufacturing

Less than half of directors are independent

Braskem S.A. Elects Eduardo Bacellar Leal Ferreira as Vice-Chairman of the Board of Directors

J&F Investimentos S.A. made an offer to acquire a 74% stake in Braskem S.A. (BOVESPA:BRKM5) from Petróleo Brasileiro S.A. - Petrobras (BOVESPA:PETR4) and Novonor S.A.

Consensus forecasts updated

Consensus forecasts updated

Full year 2021 earnings: Revenues miss analyst expectations

Braskem Expands its Circular Polymer Portfolio with New FDA Post-Consumer Recycled (PCR) Polypropylene Grades

Braskem S.A. (BOVESPA:BRKM5) acquired a minority stake in Nexus Circular LLC.

Investor sentiment improved over the past week